Sr. IP Counsel, Chemistry | Small Molecule

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit  neurocrine.com , and follow the company on  LinkedIn ,  X , Facebook and YouTube . ( *in collaboration with AbbVie ) About the Role: This position will serve as a senior intellectual property expert responsible for developing and advancing global IP strategies across multiple small molecule discovery, clinical development and commercial phase Neurocrine programs, including strategic counsel related to for licensing, collaboration, acquisition, and other strategic transactions. The role provides expert IP counsel to cross-functional and senior stakeholders, identifies and resolves complex IP issues, and influences business and portfolio strategies through deep expertise in small molecule patent and transactional matters. _ Your Contributions (include, but are not limited to): Providing strategic IP counsel to business development, research, legal, senior leadership and other cross-functional stakeholders on IP-related deal structure, risk allocation, and contractual protections, including license grants, sublicensing rights, exclusivity, improvements, background and foreground IP, patent prosecution and enforcement, and rights following termination Leading strategic IP analysis and due diligence for licensing, collaboration, acquisition, and other strategic transactions, partnering with internal and external counsel to identify, evaluate, and resolve complex IP issues involving patent portfolios, chain of title, ownership and inventorship, third-party license restrictions and encumbrances, freedom-to-operate, patent coverage, and other third-party rights. Supporting post-execution IP-related alliance and contract matters, including implementation of IP provisions and evaluation of amendments, new research activities, and additional licensing opportunities Developing and directing patent strategies, including invention identification, patent drafting, prosecution, and portfolio development, relating to small molecule pharmaceuticals Identifying and driving strategic opportunities to strengthen and expand Neurocrine's IP position in collaboration with members of various discovery, development and business groups within Neurocrine Influencing and collaborating with internal stakeholders, collaborators and other external strategic partners to develop and advance global IP strategies aligned with Neurocrine’s business and portfolio objectives Leading the IP strategy, review and negotiation of intellectual property provisions in complex life sciences transactions, including license and collaboration agreements, research agreements, option agreements, acquisitions, and other business development transactions Providing strategic IP counsel for ANDA litigation and other IP-related contentious matters, in partnership with internal stakeholders Strategically directing and managing outside legal counsel globally to ensure alignment with Neurocrine's IP objectives, business priorities, and legal strategy